Myelodysplastic Syndromes: all 2,165 studies
Page 1 of 22. Open to participants first (322), then studies with results posted, then the rest; newest registration first within each.
- Anakinra for Prevention of Poor Graft Function in MDS Allo-HSCTNot yet recruitingNCT07888348Phase 1/2
- Sonrotoclax Plus Azacitidine in Patients With MDS-IB2RecruitingNCT07885397Phase 1/2
- Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic SyndromeNot yet recruitingNCT07819396Phase 2
- Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor TypeNot yet recruitingNCT07805746
- Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNINot yet recruitingNCT07796620Phase 1/2
- Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic SyndromeNot yet recruitingNCT07780565Phase 1
- CHIP in Health and DiseaseNot yet recruitingNCT07780552
- Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia PatientsRecruitingNCT07763054
- Allogeneic iNKT Cell Therapy (agenT-797) After SCTNot yet recruitingNCT07758218Phase 1
- First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic NeoplasmsNot yet recruitingNCT07752121
- A Study to Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Red Blood Cell TransfusionsNot yet recruitingNCT07738510Phase 2
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic SyndromeNot yet recruitingNCT07737769Phase 1
- Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AMLNot yet recruitingNCT07735117Phase 3
- A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)Not yet recruitingNCT07722988Phase 3
- Dexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07698080Phase 2
- Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related DisordersRecruitingNCT07683104
- Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCTRecruitingNCT07677306Phase 2
- Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell TransplantNot yet recruitingNCT07634536Phase 2
- Chidamide Monotherapy for Intermediate-to-High-Risk Myelodysplastic SyndromesNot yet recruitingNCT07616336Phase 2
- Phase I Study of FXS0683 in the Treatment of Blood TumorsRecruitingNCT07616089Phase 1
- A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic SyndromesNot yet recruitingNCT07591168Phase 1/2
- Haplo-Cord HSCT for AML/MDSRecruitingNCT07588360Not applicable
- Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeRecruitingNCT07582172Phase 2
- Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)RecruitingNCT07579429Phase 2
- Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRSRecruitingNCT07578675
- Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationRecruitingNCT07573111Phase 1
- A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic TransplantNot yet recruitingNCT07572929Phase 2
- Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)Not yet recruitingNCT07570056
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic MalignanciesRecruitingNCT07565220Phase 1
- Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDSRecruitingNCT07532824Phase 1/2
- Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)Not yet recruitingNCT07528417Phase 2
- Dapagliflozin for Anemia in Lower-Risk Myelodysplastic SyndromesNot yet recruitingNCT07516847Phase 2
- MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological DiseasesRecruitingNCT07493538Phase 2
- eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell TransplantationRecruitingNCT07469592Not applicable
- A Trial Comparing Three Different Treatment Options for Adults With Low-Risk Myelodysplasia and Anemia (A MyeloMATCH Treatment Trial)Not yet recruitingNCT07463820Phase 2
- Study of an Innovative Therapy Using CAR-T Cells Targeting IL-1RAP in Patients With High-Risk Myelodysplastic Syndromes (MDSNot yet recruitingNCT07455500Not applicable
- IFN-α in Relapse Prevention.Not yet recruitingNCT07449286Phase 2
- A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood TransfusionsRecruitingNCT07422480Phase 3
- GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmiaNot yet recruitingNCT07372885Phase 1/2
- Asia Myelodysplastic Syndrome (MDS) RegistryRecruitingNCT07355478
- CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AMLRecruitingNCT07347418Phase 1
- Orca-T Expanded Access Program Study for Patients With Advanced Hematologic MalignanciesAvailableNCT07346105
- A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic SyndromesRecruitingNCT07319845Phase 2
- Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCTNot yet recruitingNCT07319793Not applicable
- TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTRecruitingNCT07302776Phase 1
- A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.RecruitingNCT07301866Phase 1/2
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
- FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid LeukemiaRecruitingNCT07283094Phase 1
- Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDSRecruitingNCT07270978Phase 1
- Prophylactic DLI-X for Leukemia Relapse After HCTNot yet recruitingNCT07254793Phase 1
- Study of NK Cells in the Monitoring of Patients With Acute Leukemia or MyelodysplasiaNot yet recruitingNCT07249476
- Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched DonorRecruitingNCT07238712Phase 2
- Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDSRecruitingNCT07238686Phase 2
- Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid LeukemiaRecruitingNCT07228273Phase 2
- Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeRecruitingNCT07216443Phase 2
- High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)RecruitingNCT07205523
- Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)RecruitingNCT07183878Not applicable
- Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionRecruitingNCT07155226Phase 1/2
- Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)Not yet recruitingNCT07153497Phase 2
- HPC Offered for PRESERVE ExpansionRecruitingNCT07145411
- Home Blood TransfusionsRecruitingNCT07121140Not applicable
- Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromesRecruitingNCT07107126Phase 1
- Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research StudyEnrolling by invitationNCT07102849
- Momelotinib in VEXAS SyndromeRecruitingNCT07098936Phase 2
- Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic LeukemiaRecruitingNCT07071155Early Phase 1
- Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid CancerRecruitingNCT07046078Phase 2
- Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid MalignanciesRecruitingNCT07044544Phase 1
- A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantRecruitingNCT07020533Phase 1
- Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition VariantsRecruitingNCT07019155
- Shwachman-Diamond Syndrome Global Patient Survey and Partnering PlatformRecruitingNCT06999954
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingNCT06996119Phase 1
- RVU120 Rollover StudyEnrolling by invitationNCT06987058Phase 2
- Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCTRecruitingNCT06984536Phase 2
- Mosaic Trial for Stem Cell Transplant RecipientsRecruitingNCT06960993Not applicable
- Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid LeukemiaRecruitingNCT06956755
- Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of RelapseRecruitingNCT06928662Phase 1/2
- AZA+Lus VS AZA Monotherapy in HR-MDSNot yet recruitingNCT06927232Phase 3
- Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic SyndromesRecruitingNCT06923488Phase 1/2
- Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome PatientsRecruitingNCT06918834Phase 2
- Co-Transplant of an Unmodified Haplo-Identical Graft With Cord BloodRecruitingNCT06904482Phase 2
- Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic MalignanciesRecruitingNCT06904066Phase 1
- Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms PatientsNot yet recruitingNCT06900088Phase 2
- Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical TransplantationRecruitingNCT06892223Phase 2
- Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic MalignanciesRecruitingNCT06886425Not applicable
- A Study of Momelotinib in Participants With Low-risk Myelodysplastic SyndromeRecruitingNCT06847867Phase 2
- Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDSRecruitingNCT06846606Phase 1
- A Study of XS-04 in Patients With Relapsed or Refractory Hematologic MalignanciesRecruitingNCT06820268Phase 1
- Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity ConditioningRecruitingNCT06815003Phase 2
- Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)RecruitingNCT06802315Phase 2
- Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell TransplantationRecruitingNCT06793410Phase 2
- A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringEnrolling by invitationNCT06788509Phase 1
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)RecruitingNCT06782373Phase 2
- Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or MyelofibrosisRecruitingNCT06781099Not applicable
- Oral-ATO for TP53-mutated Myeloid MalignanciesRecruitingNCT06778187Phase 2
- Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor ConditionsRecruitingNCT06773871Not applicable
- Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic SyndromeRecruitingNCT06764511
- Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with HemoblastosisRecruitingNCT06756152Phase 2/3
- Q702 for the Treatment of Patients With Hematologic MalignanciesRecruitingNCT06712810Phase 1
- Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic SyndromesRecruitingNCT06692894